TickerFactsScreenerDevelopers

Monopar Therapeutics (MNPR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$1.19M2017: -$2.63M2018: -$2.68M2019: -$3.02M2020: -$4.66M2021: -$7.32M2022: -$7.23M2023: -$7.86M2024: -$6.40M2025: -$12.20M-$12.20M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.20M-90.5%
2024-$6.40M+18.5%
2023-$7.86M-8.7%
2022-$7.23M+1.2%
2021-$7.32M-56.9%
2020-$4.66M-54.5%
2019-$3.02M-12.6%
2018-$2.68M-2.0%
2017-$2.63M-119.9%
2016-$1.19M—